GLP-1 receptor agonists have transformative potential in obesity treatment, with expanded indications expected to drive market growth. Payers face challenges balancing short-term affordability with ...

Section 1. Purpose. My first term included numerous significant actions, including some of the most aggressive in recent history, to deliver lower prescription drug prices to American patients. The ...

Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the ...

Wellgistics Health, Inc. has announced a pioneering initiative to utilize XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure, aiming to position ...

President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price negotiation program, among other policy shifts. The wide-ranging order requires ...

Editor’s note: Kathy Chang is the head of trade relations at health plan Blue Shield of California. The U.S. prescription drug market produces some of the world’s most advanced pharmaceutical ...